Structuring and centralizing breast cancer real-world biomarker data from pathology reports through C-LAB® artificial intelligence platform
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.An AI platform, C-LAB®, effectively structured breast cancer biomarker data from pathology reports, achieving over 80% agreement with human extraction. This technology promises to streamline data management for precision diagnostics.
Area Of Science
- Biomedical Informatics
- Computational Pathology
- Artificial Intelligence in Medicine
Background
- Breast cancer pathology reports are often unstructured and heterogeneous, posing challenges for data extraction.
- Centralizing biomarker data is crucial for accurate diagnostics and treatment planning.
Purpose Of The Study
- To evaluate the effectiveness of the C-LAB® artificial intelligence (AI) platform in extracting, structuring, and centralizing biomarker data from breast cancer pathology reports.
- To assess the AI platform's performance on a challenging, heterogeneous dataset from the Institut de Cancérologie de l'Ouest (ICO).
Main Methods
- The C-LAB® AI platform was deployed to analyze HER2 and hormonal receptor data from breast cancer pathology reports.
- An iterative process involving 292 reports refined the rule-based extraction algorithm.
- The finalized algorithm was applied to 2323 reports, with performance assessed against a subset (666 reports) available in the structured ESME database.
Main Results
- C-LAB® achieved over 80% agreement (precision, recall, F1-score) with human extractions for structuring biomarker data.
- The platform demonstrated effectiveness despite dataset variability and optical character recognition errors.
- The AI platform showed potential to reduce manual workload and enable scalable, real-time reporting.
Conclusions
- AI technologies like C-LAB® can transform complex pathology data into accessible digital formats.
- This facilitates precision management in diseases like breast cancer, improving diagnostics and treatment.
- C-LAB® shows significant potential for enhancing breast cancer data analysis and clinical decision-making.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.